SWAP: Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients

Sponsor
University of Tennessee (Other)
Overall Status
Completed
CT.gov ID
NCT04271917
Collaborator
(none)
68
1
4
25.2
2.7

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.

Condition or Disease Intervention/Treatment Phase
  • Drug: cannabidiol
  • Drug: placebo
  • Drug: acetaminophen 500mg and ibuprofen 200mg combo
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Since TAU participants will receive tablets instead of oil like the other 3 arms, the design is not completely double-blinded; however, the study will be double-blinded between the other three arms which all receive oil in a dropper vial.
Primary Purpose:
Treatment
Official Title:
Surgery With Alternative Pain Management (SWAP): Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients
Actual Study Start Date :
Feb 24, 2020
Actual Primary Completion Date :
Mar 31, 2022
Actual Study Completion Date :
Mar 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Treatment As Usual (TAU)

Participants will receive a 5-day supply of acetaminophen 500mg and ibuprofen 200mg. Instructions for use: Take one tablet of each medication at the same time every 4-6 hours as needed for pain.

Drug: acetaminophen 500mg and ibuprofen 200mg combo
standard of care

Placebo Comparator: Placebo

Participants will receive a 5-day supply (15mL) of inactive placebo in a dropper vial. Instructions for use: Place 0.5mL of oil under tongue for 30 seconds then swallow. Use every 4-6 hours as needed for pain.

Drug: placebo
Inactive placebo oil to imitate CBD oil

Experimental: CBD 17mg/mL

Participants will receive a 5-day supply (15mL) of cannabidiol 17mg/mL. Instructions for use: Place 0.5mL of oil under tongue for 30 seconds then swallow. Use every 4-6 hours as needed for pain.

Drug: cannabidiol
Use of cannabidiol as an alternative to standard of care treatment of acute pain.
Other Names:
  • CBD oil
  • Experimental: CBD 37 mg/mL

    Participants will receive a 5-day supply (15mL) of cannabidiol 37mg/mL. Instructions for use: Place 0.5mL of oil under tongue for 30 seconds then swallow. Use every 4-6 hours as needed for pain.

    Drug: cannabidiol
    Use of cannabidiol as an alternative to standard of care treatment of acute pain.
    Other Names:
  • CBD oil
  • Outcome Measures

    Primary Outcome Measures

    1. Worst pain following surgery using Wong Baker Faces pain scale [1-week post-op]

      Self-report of participant's worst pain after surgery

    2. Amount of medication used [1-week post-op]

      Self-report of total amount of pain medication used from participant diary

    3. Pain levels following surgery using Wong Baker Faces pain scale [First 72 hours post-op]

      Self-reported pain recorded every 2 hours between 7am-9pm by automated SMS messaging.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Presenting for an operatory appointment at University of Tennessee Health Science Center College of Dentistry Oral and Maxillofacial Surgery Department

    • Operation must be a simple tooth extraction which does not result in an opioid prescription

    • 18 years of age or older

    • Have regular and direct access to a device that can send and receive texts and willing to accept any associated charges for 24 text messages

    Exclusion Criteria:
    • Contraindication to ibuprofen

    • Contraindication to acetaminophen

    • Contraindication to cannabidiol or hemp oil

    • Contraindication to peppermint oil

    • Contraindication to almond or other tree nuts

    • Currently taking a form of cannabidiol and unwilling to stop use for one week post surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Tennessee Health Science Center Memphis Tennessee United States 38163

    Sponsors and Collaborators

    • University of Tennessee

    Investigators

    • Principal Investigator: Karen J Derefinko, PhD, University of Tennessee
    • Principal Investigator: Ammaar H Abidi, DDS, PhD, University of Tennessee

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Karen Derefinko, PhD, Assistant Professor, University of Tennessee Health Science Center
    ClinicalTrials.gov Identifier:
    NCT04271917
    Other Study ID Numbers:
    • 20-07123-XP
    First Posted:
    Feb 17, 2020
    Last Update Posted:
    May 2, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Karen Derefinko, PhD, Assistant Professor, University of Tennessee Health Science Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 2, 2022